Associate Professor, Medicine, Case Western Reserve University School of Medicine
Infectious Disease
Dr. David A. Bobak, MD
|
|
Give Review
Dr. David A. Bobak is an expert in the field of Infectious Disease. He went to The Ohio State University College of Medicine. David A. Bobak, MD is a published MD. He published 41 publications, including: 'A balance of signaling by Rho family small GTPases RhoA, Rac1 and Cdc42 coordinates cytoskeletal morphology but not cell survival.' He is registered with Medicare.
Publications
- Fecal Bacteriotherapy for Recurrent Clostridium difficile Infection: What's Old Is New Again?
- Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection.
- Hepatitis B vaccine nonresponders: a role for revaccination with the combination hepatitis A/B vaccine?
- The expanding spectrum of disease due to salmonella: an international perspective.
- Nitazoxanide to treat persistent Clostridium difficile colitis.
- Rifaximin to treat recurrent Clostridium difficile colitis.
- The molecular pathogenesis of Clostridium difficile-associated disease.
- Use of nitazoxanide for gastrointestinal tract infections: treatment of protozoan parasitic infection and beyond.
- Management of Hepatitis C in HIV-infected Patients.
- Effects of Perioperative Human Granulocyte Colony-stimulating Factor on Immune Function and Perioperative Infections in Patients Undergoing Abdominal Surgery.
- Gastrointestinal Infections Caused by Cytomegalovirus.
- Management and Prevention of Clostridium difficile-Associated Diarrhea.
- Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm?
- Human B lymphocyte colony responses. I. General characteristics and modulation by monocytes.
- Inactivation of the small GTPase Rho disrupts cellular attachment and induces adhesion-dependent and adhesion-independent apoptosis.
- Inactivation of the small GTP binding protein Rho induces multinucleate cell formation and apoptosis in murine T lymphoma EL4.
- Human B lymphocyte colony responses. II. The role of T cells in the enhancement of colony growth.
- Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages.
- Characterization of C1q receptor expression on human phagocytic cells: effects of PDBu and fMLP.
- C1q enhances the phagocytosis of Cryptococcus neoformans blastospores by human monocytes.
- Enhanced invasion of mononuclear phagocytes by serum-treated Trypanosoma cruzi is due to Clq.
- C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes.
- Complement component C1q enhances invasion of human mononuclear phagocytes and fibroblasts by Trypanosoma cruzi trypomastigotes.
- Activation of immobilized, biotinylated choleragen AI protein by a 19-kilodalton guanine nucleotide-binding protein.
- Molecular cloning, characterization, and expression of human ADP-ribosylation factors: two guanine nucleotide-dependent activators of cholera toxin.
- Structural and functional characterization of ADP-ribosylation factors, 20 kDa guanine nucleotide-binding proteins that activate cholera toxin.
- Mechanism of activation of cholera toxin by ADP-ribosylation factor (ARF): both low- and high-affinity interactions of ARF with guanine nucleotides promote toxin activ...
- Soluble guanine nucleotide-dependent ADP-ribosylation factors in activation of adenylyl cyclase by cholera toxin.
- Pre-ligation of CR1 enhances IgG-dependent phagocytosis by cultured human monocytes.
- GTP but not GDP analogues promote association of ADP-ribosylation factors, 20-kDa protein activators of cholera toxin, with phospholipids and PC-12 cell membranes.
- New developments in enteric bacterial toxins.
- Conservation of a 23-kDa human transplantation antigen in mammalian species.
- Roles of intracellular calcium and NF-kappa B in the Clostridium difficile toxin A-induced up-regulation and secretion of IL-8 from human monocytes.
- Effect of Rho and ADP-ribosylation factor GTPases on phospholipase D activity in intact human adenocarcinoma A549 cells.
- Clostridial toxins: molecular probes of Rho-dependent signaling and apoptosis.
- How intestinal bacteria cause disease.
- A balance of signaling by Rho family small GTPases RhoA, Rac1 and Cdc42 coordinates cytoskeletal morphology but not cell survival.
- Clostridium difficile toxins A and B are cation-dependent UDP-glucose hydrolases with differing catalytic activities.
- The next era of HCV antiviral therapy finally begins: part 2.
- The next era of HCV antiviral therapy finally begins: part 1.
Schools
Ohio State University College Of Medicine and Public Health
Duke University Med Center
National Institute Health
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Pathway X Tiered Hosp/Ind Direct Access OH
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- CoreSource
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- MedHealthInsurance
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Duke University Hospital -
The Ohio State University College of Medicine
Hospital
-
University Hospitals Case Medical Center
Drug Facts
| NPI NUMBER | 1114946019 | |
| NPPES Provider LastName | BOBAK | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 441061716 | |
| NPPES Provider State | OH | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 198.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114946019 |
| Last Name Of The Provider | BOBAK |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
Dr. Praveen K. Gundelly, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer Hanrahan, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dalia Elias El Bejjani, MD |
|
|
Dr. Nabin K. Shrestha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adarsh Bhimraj, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David H. Canaday, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jessica K. Fairley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle T. Hecker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zhuolin Han, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rabin K. Shrestha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas F. Keys, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Willem H. Boom, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Curtis J. Donskey, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Valsa J. Mariappuram, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carlos S. Subauste, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Wafa N. Al-Nassir, MD |
|
|
Dr. Lulette Tricia C. Bravo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph G. Toerner, MD
This Doctor is OpenDoctor Recommended.
|